Biotech1 year ago
Alfasigma Signs an Agreement with Galapagos to Buy Jyseleca Drug Assets
As part of the transaction, Galapagos will also transfer to Alfasigma the European and U.K. marketing authorizations and related commercial, medical, and development activities, as well...